Bcl-7a Polyclonal Antibody

Background:
BCL tumor suppressor 7A(BCL7A) Homo sapiens This gene is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation, the N-terminal region of the gene product is disrupted, which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma. The N-terminal segment involved in the translocation includes the region that shares a strong sequence similarity with those of BCL7B and BCL7C. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008],

Alternative Names:
BCL7A, B-cell CLL/lymphoma 7 protein family member A

Immunogen: The antiserum was produced against synthesized peptide derived from human BCL7A. AA range:21-70

Isotype: Rabbit

Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration: 1 mg/ml

Observed band: 22

GeneID: BCL7A

Storage: -20°C/1 year

NOTE: For Research Use Only